Hyper O-GlcNAcylation facilitate hepatocellular cancer growth and metastasis through a novel target

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户:ZHIWEINIU
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Hepatocellular carcinoma(HCC)is by far as the most common primary liver cancer.As a major metabolic organ,liver plays a key role in remaining nutrients including glucose,amino acid,fatty acid and nucleotide as a complicated dynamic equilibrium.
其他文献
Objective Gastric cancer(GC),one of the most aggressive gastrointestinal malignancies,has high incidence and mortality rates worldwide,especially in Asia.
目的 肺癌是全球范围内发病率及死亡率最高的恶性肿瘤之一,深入研究NSCLC 恶性生物学行为的调控机制,对阐明NSCLC 的发生发展,寻找特异性治疗靶点具有重要的意义.SOX5 是SOX 超基因家族成员,在NSCLC 中的表达及功能尚不清楚.
目的 富含亮氨酸的G蛋白耦联受体4(leucine-rich repeat containing G protein-coupledreceptor 4,LGR4)是G 蛋白耦联受体的一个重要亚型,在人体多种器官形成的过程中扮演着重要角色。
Objective Objective: This study aimed to investigate the clinical and prognostic significance of the oligodendroglial component for patients harboring glioblastomas in a large cohort.
Objective Hepatocellular carcinoma(HCC)ranks the fifth most prevalent malignancies and the second leading cause of cancerrelated death worldwide.
目的 The FLT3-ITD mutation is an independent risk factor for poor prognosis of acute myeloid leukemia(AML).Allogeneic hematopoietic stem cell transplantation(allo-HSCT)may improve the prognosis of AML w
目的 In the current study,we aimed to evaluate the expression of lnc-ABCA12-3 in ESCC and to explore the potential mechanism of lnc-ABCA12-3 in cell migration,invasion and proliferation.
目的 视网膜母细胞瘤(Retinoblastoma,RB)是儿童最常见的原发性眼内恶性肿瘤.RB可导致患儿失明、眼球丧失甚至死亡,严重威胁患儿健康.研究发现长非编码RNA(long non-codingRNA,lncRNA)在RB 发生中扮演重要角色.
Objective The genome holds extraordinary information.However,only 1.5%or less of mammalian genomes consist of protein-coding sequence.The rest of the genome,consisting of noncoding sequences,was once
Objective Lung cancer is the most frequent cause of cancer-associated deaths worldwide,and NSCLC(non-small cell lung cancer)accounts for 80%of lung cancers.